Evidence map›Paper›PMID 37765261›Full record

ArticlePharmaceutics2023

(-)-5-Demethoxygrandisin B a New Lignan from

Steven Souza Paes, João Victor Silva-Silva, Paulo Wender Portal Gomes, Luely Oliveira da Silva, Ana Paula Lima da Costa, Manoel Leão Lopes Júnior, Daiana de Jesus Hardoim, Carla J Moragas-Tellis, Noemi Nosomi Taniwaki, Alvaro Luiz Bertho and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 2 countries.

Steven Souza PaesInstitute of Exact and Natural Sciences, Federal University of Pará, Belém 66075-110, PA, Brazil.ORCID 0000-0001-6135-8397
João Victor Silva-SilvaLaboratory of Protozoology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro 21041-250, RJ, Brazil.ORCID 0000-0002-7064-2610
Paulo Wender Portal GomesCollaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, CA 92123, USA.ORCID 0000-0001-5478-2448
Luely Oliveira da SilvaDepartment of Natural Sciences, Pará State University, Belém 66095-015, PA, Brazil.
Ana Paula Lima da CostaInstitute of Exact and Natural Sciences, Federal University of Pará, Belém 66075-110, PA, Brazil.
Manoel Leão Lopes JúniorInstitute of Exact and Natural Sciences, Federal University of Pará, Belém 66075-110, PA, Brazil.
Daiana de Jesus HardoimLaboratory of Protozoology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro 21041-250, RJ, Brazil.ORCID 0000-0002-2272-2472
Carla J Moragas-TellisLaboratory of Natural Products for Public Health, Pharmaceutical Technology Institute, Farmanguinhos, Oswaldo Cruz Foundation, Rio de Janeiro 21040-900, RJ, Brazil.
Noemi Nosomi TaniwakiElectron Microscopy Nucleus, Adolfo Lutz Institute, São Paulo 01246-000, SP, Brazil.
Alvaro Luiz BerthoLaboratory of Immunoparasitology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro 21040-900, RJ, Brazil.
Fábio Alberto de MolfettaLaboratory of Molecular Modeling, Institute of Exact and Natural Sciences, Federal University of Pará, Belém 66075-110, PA, Brazil.ORCID 0000-0002-6773-6923
Fernando Almeida-SouzaLaboratory of Protozoology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro 21041-250, RJ, Brazil.ORCID 0000-0003-0047-6159
Lourivaldo Silva SantosInstitute of Exact and Natural Sciences, Federal University of Pará, Belém 66075-110, PA, Brazil.
Kátia da Silva CalabreseLaboratory of Protozoology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro 21041-250, RJ, Brazil.
Universidade Federal do Pará · BRFundação Oswaldo Cruz · BRInstituto Adolfo Lutz · BRUniversidade de São Paulo · BRUniversidade do Estado do Pará · BRUniversidade Estadual do Maranhão · BRUniversity of California San Diego · US

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior 8887.200524/2018-00Coordenação de Aperfeicoamento de Pessoal de Nível Superior 88887.363006/2019-00Coordenação de Aperfeicoamento de Pessoal de Nível Superior 88887.368507/2019-00Coordenação de Aperfeicoamento de Pessoal de Nível Superior Finance Code 001Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro E-26/110332/2014Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro E-26/201.765/2019Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro E-26/210.344/2019Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro E-26/211.680/2021 (269680)National Council for Scientific and Technological Development 315225/2021-1
6 · The paper itself

Abstract

Leishmaniasis is a complex disease caused by infection with different

Indexed as

computational studiesflow cytometryLeishmania amazonensismitochondrial membrane potentialtrypanothione reductase

Identifiers

PMID37765261
PMCPMC10535778
OpenAlexW4386526351

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.